Header Logo

Idoroenyi Amanam, MD

TitleClinical Assistant Professor
InstitutionCharles R. Drew University of Medicine and Science
DepartmentBiomedical Science Ed.
Address1731 E. 120th Street
Los Angeles CA 90059
PhoneNot Available
FaxNot Available
vCardDownload vCard

    Bibliographic
    selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Othman T, Agrawal V, Song JY, Gu Z, Koller P, Pourhassan H, Samara Y, Thiebaud JA, Tinajero J, Ngo D, Lin R, Sandhu K, AlMalki M, Aribi A, Otoukesh S, Ball B, Artz A, Salhotra A, Khaled S, Blackmon A, Amanam I, Ali H, Park S, Becker P, Nakamura R, Marcucci G, Stein A, Forman S, Pullarkat V, Aldoss I. Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia. Am J Hematol. 2026 Jul 23. PMID: 42493343.
      Citations:    Fields:    
    2. Othman T, Yang D, Shouse G, Pourhassan H, Otoukesh S, Farol L, Popplewell LL, Aribi A, Herrera AF, Mansour J, Mei M, Sandhu KS, Siddiqi T, Agrawal V, Amanam I, Pullarkat V, Phillips TJ, Ali H, Budde LE, Nakamura R, Forman SJ, Aldoss I, Al Malki MM. Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Versus-Host Disease and Nonrelapse Mortality After Allogeneic Transplantation. Transplant Cell Ther. 2026 Jul 10. PMID: 42431379.
      Citations:    Fields:    
    3. Ngo D, Tinajero J, Sandhu K, Amanam I, Otoukesh S, Arslan S, Park S, Ali H, Modi B, Nakamura R, Salhotra A. The Effect of Belumosudil on the Therapeutic Drug Levels of Tacrolimus and Sirolimus in Allogeneic Hematopoietic Transplantation. Transplant Cell Ther. 2026 Jun 16. PMID: 42302963.
      Citations:    Fields:    
    4. Samuels DT, Ball BJ, Tsai NC, Otoukesh S, Arslan S, Pourhassan H, Blackmon A, Agrawal V, Amanam I, Ali H, Salhotra A, Aldoss I, Koller P, Aribi A, Sandhu K, Artz A, Smith E, Stewart F, Becker P, Al Malki MM, Stein A, Marcucci G, Forman SJ, Nakamura R, Pullarkat V. Hypomethylating agents-venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCT. Blood Neoplasia. 2026 Aug; 3(3):100257. PMID: 42499388; PMCID: PMC13396606.
      Citations:    
    5. Perez JMR, Shan H, Yang D, Chien L, Uranga C, Salman J, Aldoss I, Ali H, Agrawal V, Amanam I, Aribi A, Armenian S, Arslan S, Ball B, Blackmon A, Becker P, Koller P, Otoukesh S, Pourhassan H, Pullarkat V, Salhotra A, Sandhu KS, Spielberger R, Stein A, Dale W, Smith E, Marcucci G, Forman SJ, Malki MMA, Nakamura R, Artz AS. Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. 2026 Jul; 32(7):877.e1-877.e11. PMID: 41911976.
      Citations:    Fields:    Translation:Humans
    6. Amanam I, Otoukesh S, Pullarkat V, Ghoda L, Forman S, Marcucci G, Al Malki M, Ali H. Myelofibrosis-associated extramedullary hematopoiesis: Insights into hepatic, pulmonary, and thrombotic complications. Blood Rev. 2026 Jan; 75:101355. PMID: 41344966.
      Citations:    Fields:    Translation:Humans
    7. Tinajero J, Ngo D, Lee B, Kim H, Ball B, Koller P, Amanam I, Pourhassan H, Ali H, Otoukesh S, Salhotra A, Blackmon A, Sandhu K. FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experience. J Oncol Pharm Pract. 2026 Apr; 32(3):555-559. PMID: 41264473.
      Citations:    Fields:    Translation:Humans
    8. Salhotra A, Yang D, Al Malki MM, Mokhtari S, Knobler D, Agarwal V, Sandhu K, Park G, Aribi A, Ali H, Aldoss I, Otoukesh S, Arslan S, Ball B, Koller P, Amanam I, Pourhassan H, Blackmon A, Becker P, Pullarkat V, Artz AS, Smith E, Marcucci G, Forman S, Stein A, Nakamura R. Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis. Bone Marrow Transplant. 2026 01; 61(1):82-91. PMID: 41254192; PMCID: PMC12819140.
      Citations:    Fields:    Translation:Humans
    9. Harada K, Zhao D, Park M, Chen F, Xu Y, Zhang Y, Zhou Y, Parcutela B, Jewel Y, Munoz A, Amanam I, Nguyen LXT, Chen J, Ghoda L, Forman SJ, Williams JC, Zhang B, Marcucci G. MicroRNA-142 improves IL1RAP CAR-T cell activity in acute myeloid leukemia. J Hematol Oncol. 2025 11 12; 18(1):99. PMID: 41225489; PMCID: PMC12613351.
      Citations:    Fields:    Translation:HumansAnimalsCells
    10. Otoukesh S, Amanam I, Yang D, Samuels D, Salhotra A, Artz A, Arslan S, Aldoss I, Sandhu K, Koller P, Aribi A, Curtin P, Stein A, Marcucci G, Al Malki M, Ali H, Rahmanuddin S, Nakamura R, Pullarkat V. Pulmonary manifestations during neutrophil engraftment in recipients of allogeneic hematopoietic cell transplantation for myelofibrosis. Bone Marrow Transplant. 2025 Dec; 60(12):1666-1668. PMID: 40993219.
      Citations:    Fields:    
    11. Nguyen T, Markary T, Tsai NC, Tiemann K, Mokhtari S, Samara Y, Pourhassan H, Blackmon A, Arslan S, Otoukesh S, Agarwal V, Amanam I, Ball B, Koller P, Aribi A, Salhotra A, Sandhu K, Pullarkat V, Becker P, Aldoss I, Ali H, Stewart F, Smith E, Stein A, Marcucci G, Forman SJ, Artz A, Nakamura R, Al Malki MM. Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal Impairment. Transplant Cell Ther. 2025 Oct; 31(10):824.e1-824.e13. PMID: 40617293; PMCID: PMC12416212.
      Citations: 1     Fields:    Translation:Humans
    12. Ngo D, Tinajero J, Otoukesh S, Sandhu K, Ali H, Arslan S, Modi B, Amanam I, Nakamura R, Salhotra A. Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease. Expert Opin Investig Drugs. 2025 May; 34(5):391-400. PMID: 40407836.
      Citations: 1     Fields:    Translation:HumansAnimals
    13. Aldoss I, Li S, Zhang J, Clark MC, Agrawal V, Pourhassan H, Koller P, Aribi A, Ali H, Blackmon A, Otoukesh S, Sandhu K, Ball B, Arslan S, Artz A, Amanam I, Al Malki MM, Salhotra A, Kovacsovics T, Murphy L, Afkhami M, Ngo D, Tinajero J, Gu Z, Becker PS, Nakamura R, Stein A, Marcucci G, Forman SJ, Pullarkat V. TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALL. Blood Adv. 2025 May 13; 9(9):2159-2172. PMID: 39820649; PMCID: PMC12242962.
      Citations: 5     Fields:    Translation:Humans
    14. Koller PB, Othman T, Yang D, Mokhtari S, Samara Y, Blackmon A, Agrawal V, Pourhassan H, Ball BJ, Amanam I, Arslan S, Otoukesh S, Sandhu KS, Aldoss I, Ali H, Salhotra A, Aribi A, Artz A, Becker PS, Pullarkat V, Stewart FM, Smith EP, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect. Bone Marrow Transplant. 2025 May; 60(5):625-631. PMID: 40016513; PMCID: PMC12061766.
      Citations: 2     Fields:    Translation:Humans
    15. Samuels DT, Yao JM, Samara Y, Yang D, Mokhtari S, Tiemann K, Otoukesh S, Arslan S, Pourhassan H, Wu S, Blackmon A, Agrawal V, Amanam I, Ali H, Salhotra A, Aldoss I, Ball B, Koller P, Aribi A, Sandhu K, Pullarkat V, Artz A, Smith E, Stewart F, Becker P, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis. Front Immunol. 2025; 16:1543099. PMID: 40051639; PMCID: PMC11882550.
      Citations: 1     Fields:    Translation:Humans
    16. Modi B, Ngo D, Chen J, Yang D, Shan H, Sandhu K, Rashid N, Amanam I, Otoukesh S, Nakamura R, Ali H, Salhotra A. Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience. Bone Marrow Transplant. 2025 Apr; 60(4):555-557. PMID: 39905130.
      Citations: 2     Fields:    
    17. Blackmon A, Afkhami M, Yang D, Mokhtari S, Samara Y, Pourhassan H, Ball B, Salhotra A, Agrawal V, Sandhu K, Desai A, Otoukesh S, Arslan S, Amanam I, Koller P, Tinajero J, Aribi A, Aldoss I, Becker P, Artz A, Ali H, Stein A, Smith E, Pullarkat V, Forman SJ, Marcucci G, Nakamura R, Al Malki MM. Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual disease. Bone Marrow Transplant. 2025 02; 60(2):165-174. PMID: 39695333; PMCID: PMC11810767.
      Citations:    Fields:    Translation:Humans
    18. Pourhassan H, Nguyen T, Yang D, Otoukesh S, Arslan S, Blackmon A, Agrawal V, Amanam I, Ball B, Koller P, Salhotra A, Aribi A, Becker P, Curtin P, Artz A, Aldoss I, Ali H, Stewart F, Smith E, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD). Cancers (Basel). 2024 Nov 22; 16(23). PMID: 39682101; PMCID: PMC11640275.
      Citations: 1     
    19. Xie Z, Komrokji R, Al Ali N, Regelson A, Geyer S, Patel A, Saygin C, Zeidan AM, Bewersdorf JP, Mendez L, Kishtagari A, Zeidner JF, Coombs CC, Madanat YF, Chung S, Badar T, Foran J, Desai P, Tsai C, Griffiths EA, Al Malki MM, Amanam I, Lai C, Deeg HJ, Ades L, Arana Yi C, Osman AEG, Dinner S, Abaza Y, Taylor J, Chandhok N, Soong D, Brunner AM, Carraway HE, Singh A, Elena C, Ferrari J, Gall? A, Pozzi S, Padron E, Patnaik MM, Malcovati L, Savona MR, Al-Kali A. Risk prediction for clonal cytopenia: multicenter real-world evidence. Blood. 2024 Nov 07; 144(19):2033-2044. PMID: 38996210; PMCID: PMC11561536.
      Citations: 22     Fields:    Translation:Humans
    20. Fei F, Jariwala A, Pullarkat S, Loo E, Liu Y, Tizro P, Ali H, Otoukesh S, Amanam I, Artz A, Ally F, Telatar M, Nakamura R, Marcucci G, Afkhami M. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. Int J Mol Sci. 2024 Sep 23; 25(18). PMID: 39337700; PMCID: PMC11431978.
      Citations: 4     Fields:    Translation:Humans
    21. Desai A, Samara Y, Yang D, Ball B, Braun A, Koller P, Blackmon A, Agrawal V, Pourhassan H, Amanam I, Arslan S, Otoukesh S, Sandhu K, Aldoss I, Ali H, Salhotra A, Al Malki MM, Artz A, Becker P, Smith E, Stein A, Marcucci G, Forman SJ, Curtin P, Nakamura R, Pullarkat V. Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation. Leuk Res. 2024 10; 145:107565. PMID: 39208597.
      Citations: 2     Fields:    Translation:HumansCells
    22. Ngo D, Tinajero J, Ladha A, Malki MMA, Otoukesh S, Amanam I, Ali H. Hypomethylating Agents are Effective in Treatment for Relapsed Myelofibrosis After Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 11; 30(11):1091.e1-1091.e8. PMID: 39187159.
      Citations: 2     Fields:    Translation:HumansCells
    23. Otoukesh S, Yang D, Mokhtari S, Pourhassan H, Agrawal V, Arslan S, Amanam I, Ball B, Koller P, Salhotra A, Sandhu K, Aribi A, Artz A, Aldoss I, Pullarkat V, Ali H, Blackmon A, Becker P, Curtin P, Stewart F, Smith E, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings. Bone Marrow Transplant. 2024 Nov; 59(11):1542-1551. PMID: 39147891; PMCID: PMC11530400.
      Citations:    Fields:    Translation:Humans
    24. Zhang Y, Park M, Ghoda LY, Zhao D, Valerio M, Nafie E, Gonzalez A, Ly K, Parcutela B, Choi H, Gong X, Chen F, Harada K, Chen Z, Nguyen LXT, Pichiorri F, Chen J, Song J, Forman SJ, Amanam I, Zhang B, Jin J, Williams JC, Marcucci G. IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells. J Hematol Oncol. 2024 08 14; 17(1):67. PMID: 39143574; PMCID: PMC11325815.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    25. Arslan S, Desai A, Yang D, Mokhtari S, Tiemann K, Otoukesh S, Samara Y, Blackmon A, Agrawal V, Pourhassan H, Amanam I, Ball B, Koller P, Salhotra A, Aribi A, Becker P, Curtin P, Artz A, Aldoss I, Ali H, Stewart F, Smith E, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 10; 30(10):1013.e1-1013.e12. PMID: 39122188; PMCID: PMC11809593.
      Citations: 2     Fields:    Translation:Humans
    26. Tinajero J, Ngo D, Zhang J, Tsai NC, Aribi A, Aldoss I, Agrawal V, Arslan S, Amanam I, Pourhassan H, Sandhu K, Al-Malki M, Pullarkat V, Becker P, Nakamura R, Stein A, Marcucci G, Artz A, Koller P, Salhotra A. High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy. Leuk Lymphoma. 2024 07; 65(7):1020-1023. PMID: 38635368.
      Citations:    Fields:    Translation:Humans
    27. Amanam I, Otoukesh S, Al Malki MM, Salhotra A. Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies. Hematology Am Soc Hematol Educ Program. 2023 12 08; 2023(1):164-170. PMID: 38066845; PMCID: PMC10727045.
      Citations: 6     Fields:    Translation:HumansAnimals
    28. Yao JM, Otoukesh S, Kim H, Yang D, Mokhtari S, Samara Y, Blackmon A, Arslan S, Agrawal V, Pourhassan H, Amanam I, Ball B, Koller P, Salhotra A, Becker P, Curtin P, Artz A, Aldoss I, Ali H, Stewart F, Smith E, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. Transplant Cell Ther. 2023 08; 29(8):515.e1-515.e7. PMID: 37182736; PMCID: PMC10527340.
      Citations: 4     Fields:    Translation:Humans
    29. Amanam I, Yao J, Puing A, Tsai NC, Samuels D, Ngo D, Ho S, Ali H, Aribi A, Arslan S, Artz A, Htut M, Koller P, Salhotra A, Sandhu K, Nikolaenko L, Pawlowska A, Shouse G, Stein A, Marcucci G, Forman S, Nakamura R, Dadwal S, Al Malki MM. Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience. Cancer Med. 2023 05; 12(10):11248-11253. PMID: 37081733; PMCID: PMC10242327.
      Citations: 2     Fields:    Translation:HumansCells
    30. Aldoss I, Afkhami M, Yang D, Gu Z, Mokhtari S, Shahani S, Pourhassan H, Agrawal V, Koller P, Arslan S, Tomasian V, Al Malki MM, Artz A, Salhotra A, Ali H, Aribi A, Sandhu KS, Ball B, Otoukesh S, Amanam I, Becker PS, Stewart FM, Curtin P, Smith E, Telatar M, Stein AS, Marcucci G, Forman SJ, Nakamura R, Pullarkat V. High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions. Am J Hematol. 2023 06; 98(6):848-856. PMID: 36880203.
      Citations: 5     Fields:    Translation:Humans
    31. La Rosa C, Chiuppesi F, Park Y, Zhou Q, Yang D, Gendzekhadze K, Ly M, Li J, Kaltcheva T, Ortega Francisco S, Gutierrez MA, Ali H, Otoukesh S, Amanam I, Salhotra A, Pullarkat VA, Aldoss I, Rosenzweig M, Aribi AM, Stein AS, Marcucci G, Dadwal SS, Nakamura R, Forman SJ, Al Malki MM, Diamond DJ. Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study. Front Immunol. 2023; 14:1114131. PMID: 36936918; PMCID: PMC10020189.
      Citations: 3     Fields:    Translation:HumansCells
    32. Agrawal V, Pourhassan H, Tsai NC, Ngo D, Koller P, Malki MMA, Salhotra A, Ali H, Aribi A, Sandhu KS, Arslan S, Ball B, Otoukesh S, Amanam I, Artz A, Singh D, Becker PS, Stewart FM, Smith EP, Curtin P, Stein AS, Marcucci G, Forman SJ, Nakamura R, Pullarkat V, Aldoss I. Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab. Transplant Cell Ther. 2023 05; 29(5):314-320. PMID: 36682470.
      Citations: 7     Fields:    Translation:Humans
    33. Ball BJ, Arslan S, Koller P, Ngo D, Afkhami M, Salhotra A, Al-Malki M, Aribi A, Ali H, Sandhu K, Otoukesh S, Amanam I, Pourhassan H, Artz A, Curtin P, Stein A, Nakamura R, Marcucci G, Smith E, Pullarkat V, Aldoss I. Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML). Leuk Lymphoma. 2022 12; 63(13):3232-3236. PMID: 36089918.
      Citations: 9     Fields:    Translation:Humans
    34. La Rosa C, Chiuppesi F, Park Y, Gendzekhadze K, Zhou Q, Faircloth K, Kaltcheva T, Johnson D, Ortega Francisco S, Amanam I, Otoukesh S, Pullarkat VA, Nakamura R, Diamond DJ, Forman SJ, Al Malki MM. Adoptive transfer of functional SARS-COV-2-specific immunity from donor graft to hematopoietic stem cell transplant recipients. Am J Hematol. 2022 11; 97(11):E404-E407. PMID: 36053823; PMCID: PMC9537795.
      Citations: 3     Fields:    Translation:HumansCells
    35. Amanam I, Ngo D, Pullarkat V, Aldoss I. Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysis. Leuk Lymphoma. 2022 12; 63(13):3268-3270. PMID: 36016465.
      Citations:    Fields:    Translation:Humans
    36. Yao JM, Yang D, Clark MC, Otoukesh S, Cao T, Ali H, Arslan S, Aldoss I, Artz A, Amanam I, Salhotra A, Pullarkat V, Sandhu K, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens. Bone Marrow Transplant. 2022 02; 57(2):232-242. PMID: 34802049; PMCID: PMC8825746.
      Citations: 7     Fields:    Translation:Humans
    37. Amanam I, Gupta R, Pullarkat V, Mei M. Immune thrombocytopenia after immune checkpoint inhibitor therapy. Br J Haematol. 2021 05; 193(3):677-681. PMID: 33713434.
      Citations: 2     Fields:    Translation:Humans
    38. Amanam I, Mambetsariev I, Gupta R, Achuthan S, Wang Y, Pharaon R, Massarelli E, Koczywas M, Reckamp K, Salgia R. Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival. J Thorac Dis. 2020 Sep; 12(9):5086-5095. PMID: 33145085; PMCID: PMC7578487.
      Citations: 33     
    39. Amanam I, Mambetsariev I, Gupta R, Salgia R. Progressive Neurologic Changes in a Patient With Metastatic Non-Small-Cell Lung Cancer: Cancer Effects or a Secondary Diagnosis? JCO Oncol Pract. 2021 01; 17(1):52-53. PMID: 32644904.
      Citations:    Fields:    Translation:Humans
    40. Gupta R, Othman T, Uche A, Amanam I, Chen C, Celles L, Lane G, Mei M, Aldoss I, Pullarkat V, Kim P, Yeh J. Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital. Clin Lymphoma Myeloma Leuk. 2020 06; 20(6):e320-e327. PMID: 32199763.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    41. Mambetsariev I, Wang Y, Chen C, Nadaf S, Pharaon R, Fricke J, Amanam I, Amini A, Bild A, Chu P, Erhunmwunsee L, Kim J, Munu J, Pillai R, Raz D, Sampath S, Vora L, Qiu F, Smith L, Batra SK, Massarelli E, Koczywas M, Reckamp K, Salgia R. Precision medicine and actionable alterations in lung cancer: A single institution experience. PLoS One. 2020; 15(2):e0228188. PMID: 32045431; PMCID: PMC7012442.
      Citations: 6     Fields:    Translation:Humans
    42. Afkhami M, Schmolze D, Yost SE, Frankel PH, Dagis A, Amanam IU, Telatar M, Nguyen K, Yu KW, Luu T, Pillai R, Aoun PA, Mortimer J, Yuan Y. Mutation and immune profiling of metaplastic breast cancer: Correlation with survival. PLoS One. 2019; 14(11):e0224726. PMID: 31693690; PMCID: PMC6834262.
      Citations: 21     Fields:    Translation:Humans
    43. Schrock AB, Ouyang C, Sandhu J, Sokol E, Jin D, Ross JS, Miller VA, Lim D, Amanam I, Chao J, Catenacci D, Cho M, Braiteh F, Klempner SJ, Ali SM, Fakih M. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Ann Oncol. 2019 07 01; 30(7):1096-1103. PMID: 31038663.
      Citations: 374     Fields:    Translation:Humans
    44. Gupta R, Amanam I, Rahmanuddin S, Mambetsariev I, Wang Y, Huang C, Reckamp K, Vora L, Salgia R. Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma. Am J Clin Oncol. 2019 04; 42(4):337-344. PMID: 30741758; PMCID: PMC7597761.
      Citations: 7     Fields:    Translation:Humans
    45. Hill A, Gupta R, Zhao D, Vankina R, Amanam I, Salgia R. Targeted Therapies in Non-small-Cell Lung Cancer. Cancer Treat Res. 2019; 178:3-43. PMID: 31209840.
      Citations: 11     Fields:    Translation:Humans
    46. S?cher T, Guilleminault L, Reckamp K, Amanam I, Plantier L, Heuz?-Vourc'h N. Therapeutic antibodies: A new era in the treatment of respiratory diseases? Pharmacol Ther. 2018 09; 189:149-172. PMID: 29730443.
      Citations: 13     Fields:    Translation:HumansAnimals
    47. Amanam I, Gupta R, Mambetsariev I, Salgia R. The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer. Future Oncol. 2018 Aug; 14(19):1897-1908. PMID: 29451020.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    48. Amanam I, Chung V. Targeted Therapies for Pancreatic Cancer. Cancers (Basel). 2018 Jan 29; 10(2). PMID: 29382159; PMCID: PMC5836068.
      Citations: 34     
    49. Amanam I, Gupta R, Mita A, Scher K, Massarelli E. Perspectives in Head and Neck Medical Oncology. Cancer Treat Res. 2018; 174:163-185. PMID: 29435842.
      Citations: 3     Fields:    Translation:Humans
    50. Gupta R, Amanam I, Chung V. Current and future therapies for advanced pancreatic cancer. J Surg Oncol. 2017 Jul; 116(1):25-34. PMID: 28591939.
      Citations: 83     Fields:    Translation:Humans
    51. Chan JK, James SL, Gardner AB, Amanam I, Kapp DS. A Comparative Study of Minimally Invasive Versus Open Hysterectomy for Women With Fibroid Uterus - A Nationwide Study of 65,216 Patients. J Minim Invasive Gynecol. 2015 Nov-Dec; 22(6S):S62. PMID: 27679294.
      Citations:    Fields:    
    52. Chan JK, Kiet TK, Monk BJ, Young-Lin N, Blansit K, Kapp DS, Amanam I. Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviews. Oncologist. 2014 Mar; 19(3):299-304. PMID: 24599479; PMCID: PMC3958455.
      Citations: 1     Fields:    Translation:Humans
    Amanam's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (171)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _